{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T19:41:44Z","timestamp":1782330104751,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ajem.2020.08.042","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T01:53:53Z","timestamp":1597629233000},"page":"2713-2717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The efficacy of inhaled hypertonic saline for bronchiectasis: a meta-analysis of randomized controlled studies"],"prefix":"10.1016","volume":"38","author":[{"given":"Bingfeng","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weineng","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.ajem.2020.08.042_bb0005","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMra012519","article-title":"Bronchiectasis","volume":"346","author":"Barker","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ajem.2020.08.042_bb0010","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1183\/09031936.00069007","article-title":"Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms","volume":"31","author":"Fuschillo","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ajem.2020.08.042_bb0015","article-title":"Airways mucus pathogenesis in patients with non-cystic fibrosis bronchiectasis","author":"Ramsey","year":"2018","journal-title":"Eur Respiratory Soc"},{"issue":"3","key":"10.1016\/j.ajem.2020.08.042_bb0020","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MCP.0000000000000569","article-title":"Bronchiectasis phenotypes","volume":"25","author":"Chang-Macchiu","year":"2019","journal-title":"Curr Opin Pulm Med"},{"issue":"7","key":"10.1016\/j.ajem.2020.08.042_bb0025","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/17476348.2018.1481392","article-title":"Current and future pharmacotherapy options for non-cystic fibrosis bronchiectasis","volume":"12","author":"Athanazio","year":"2018","journal-title":"Expert Rev Respir Med"},{"issue":"3","key":"10.1016\/j.ajem.2020.08.042_bb0030","doi-asserted-by":"crossref","first-page":"1800328","DOI":"10.1183\/13993003.00328-2018","article-title":"The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions","volume":"52","author":"Polverino","year":"2018","journal-title":"Eur Respir J"},{"issue":"Suppl. 1","key":"10.1016\/j.ajem.2020.08.042_bb0035","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thx.2010.136119","article-title":"British Thoracic Society guideline for non-CF bronchiectasis","volume":"65","author":"Pasteur","year":"2010","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.ajem.2020.08.042_bb0040","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/thx.2006.065664","article-title":"Pulmonary exacerbations in cystic fibrosis and bronchiectasis","volume":"62","author":"Elborn","year":"2007","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.ajem.2020.08.042_bb0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1479972308091823","article-title":"Quality of life and inflammation in exacerbations of bronchiectasis","volume":"5","author":"Courtney","year":"2008","journal-title":"Chron Respir Dis"},{"issue":"2","key":"10.1016\/j.ajem.2020.08.042_bb0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/QCO.0b013e3282f4f237","article-title":"Bronchiectasis: new findings in the pathogenesis and treatment of this disease","volume":"21","author":"Ilowite","year":"2008","journal-title":"Curr Opin Infect Dis"},{"issue":"5","key":"10.1016\/j.ajem.2020.08.042_bb0055","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/thoraxjnl-2015-206956","article-title":"Reclaiming the name 'bronchiectasis'","volume":"70","author":"Chalmers","year":"2015","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.ajem.2020.08.042_bb0060","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J"},{"issue":"Suppl 2(Suppl 2)","key":"10.1016\/j.ajem.2020.08.042_bb0065","first-page":"S186","article-title":"Hydrator therapies for chronic Bronchitis. Lessons from Cystic Fibrosis","volume":"13","author":"Bennett","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.ajem.2020.08.042_bb0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.rmed.2004.05.006","article-title":"Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis","volume":"99","author":"Kellett","year":"2005","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.ajem.2020.08.042_bb0075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/jamp.2017.1443","article-title":"Impact of hypertonic saline solutions on sputum expectoration and their safety profile in patients with bronchiectasis: a randomized crossover trial","volume":"31","author":"Herrero-Cortina","year":"2018","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"5","key":"10.1016\/j.ajem.2020.08.042_bb0080","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.rmed.2011.12.021","article-title":"The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis","volume":"106","author":"Nicolson","year":"2012","journal-title":"Respir Med"},{"issue":"12","key":"10.1016\/j.ajem.2020.08.042_bb0085","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.rmed.2011.07.019","article-title":"Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis","volume":"105","author":"Kellett","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.ajem.2020.08.042_bb0090","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"Bmj"},{"key":"10.1016\/j.ajem.2020.08.042_bb0095","article-title":"Cochrane handbook for systematic reviews of interventions version 5.1. 0 [updated march 2011]","author":"HigginsJPT","year":"2011","journal-title":"Cochrane Collab"},{"issue":"1","key":"10.1016\/j.ajem.2020.08.042_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"issue":"11","key":"10.1016\/j.ajem.2020.08.042_bb0105","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported Methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.ajem.2020.08.042_bb0110","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"5","key":"10.1016\/j.ajem.2020.08.042_bb0115","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1034\/j.1399-3003.1999.13e39.x","article-title":"Regulation of mucociliary clearance in health and disease","volume":"13","author":"Houtmeyers","year":"1999","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ajem.2020.08.042_bb0120","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/089426802760292681","article-title":"Osmotic stimuli increase clearance of mucus in patients with mucociliary dysfunction","volume":"15","author":"Daviskas","year":"2002","journal-title":"J Aerosol Med"},{"issue":"1","key":"10.1016\/j.ajem.2020.08.042_bb0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1179\/108331906X98877","article-title":"Airway clearance in the spontaneously breathing adult \u2013 the evidence","volume":"11","author":"Pryor","year":"2006","journal-title":"Phys Ther Rev"},{"issue":"5","key":"10.1016\/j.ajem.2020.08.042_bb0130","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1183\/09031936.00055509","article-title":"A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis","volume":"34","author":"Murray","year":"2009","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.ajem.2020.08.042_bb0135","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1440-1843.2003.00454.x","article-title":"Effect of osmolality on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum","volume":"8","author":"Shibuya","year":"2003","journal-title":"Respirology (Carlton, Vic)"},{"issue":"11","key":"10.1016\/j.ajem.2020.08.042_bb0140","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1164\/rccm.201101-0072OC","article-title":"Nebulized hypertonic saline decreases IL-8 in sputum of patients with cystic fibrosis","volume":"183","author":"Reeves","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.ajem.2020.08.042_bb0145","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa043900","article-title":"A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis","volume":"354","author":"Elkins","year":"2006","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ajem.2020.08.042_bb0150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa043891","article-title":"Mucus clearance and lung function in cystic fibrosis with hypertonic saline","volume":"354","author":"Donaldson","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ajem.2020.08.042_bb0155","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1164\/rccm.201005-0756OC","article-title":"A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis","volume":"183","author":"Murray","year":"2011","journal-title":"Am J Respir Crit Care Med"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675720307397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675720307397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:51:48Z","timestamp":1760025108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675720307397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0735675720307397"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2020.08.042","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy of inhaled hypertonic saline for bronchiectasis: a meta-analysis of randomized controlled studies","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2020.08.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}